X Sun, S Xu, Z Yang, P Zheng*, W Zhu*. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: a patent review (2014-present). Expert Opinion on Therapeutic Patents,2021, 31 (3), 223-238. (IF=6.674)